Cure My Disease

Don't miss your cure!

 Log in / Sign up

15,000 cancer Patients' data to unlock surgery secrets

NCT ID NCT02526095

Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is building a large database of 15,000 patients with esophageal or gastric cancers in France. Researchers will look back at medical records to see how patients fared after surgery, focusing on how long they stayed cancer-free. The goal is to learn more about survival, complications, and recurrence rates to improve future care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could provide valuable insights into long-term outcomes after surgery for esophageal and gastric cancers, helping guide future treatment decisions.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly benefit participants. Results may be limited by the quality of existing medical records.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 15,000 people

The number the study aims to enrol. It can still change while the study runs.

Start date

Jun 2014

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients with gastroesophageal cancer diagnosed and treatment-naïve, if not receiving neoadjuvant treatment in a participating center will be included after acceptance and signature of consent, whether operated or not, whatever histologic type, tumor stage, and the therapeutic strategy.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patient with * esophageal cancer, gastric or gastroesophageal junction diagnosed biopsy , regardless of the subtype of cancer, tumor stage or treatment envisaged. * Naive treatment for this cancer, * Naive treatment for this cancer , failing that received neoadjuvant treatment , * Male or female ≥ 18 years. * social protection scheme . * sign a free and informed consent for blood sampling , the different questionnaires and the collection of patient information. Exclusion Criteria: Male or female aged ( e) under 18 years. * Private person of liberty or under supervision (including guardianship ) . * People who do not speak French. * Major Nobody unable to consent . * Patient FREGAT already included in the base. * Patient Refusal .

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Esophageal cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal cancer esophageal disorder gastric cancer gastroesophageal junction adenocarcinoma gastrointestinal stromal tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Esophageal disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    31 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aphm Hopital Nord

    RECRUITING

    Marseille, France

  • C H U Dupuytren Limoges

    RECRUITING

    Limoges, France

  • Chru Besancon

    RECRUITING

    Besançon, France

  • Chru Rennes Site Pontchaillou

    RECRUITING

    Rennes, France

  • Chu Amiens Picardie

    RECRUITING

    Amiens, France

  • Chu Nimes

    RECRUITING

    Nîmes, France

  • Chu de Caen Normandie

    RECRUITING

    Caen, France

  • Chu de Grenoble Alpes

    RECRUITING

    Grenoble, France

  • Chu de Nantes :Site Hôtel-Dieu- Hme

    RECRUITING

    Nantes, France

  • Chu de Tours

    RECRUITING

    Tours, France

  • Clcc Oscar Lambret Lille

    RECRUITING

    Lille, France

  • Crlcc Francois Baclesse

    RECRUITING

    Caen, France

  • Hop Claude Huriez Chu Lille

    RECRUITING

    Lille, 59045, France

  • Hopital Charles Nicolle Chu Rouen

    RECRUITING

    Rouen, France

  • Hopital Estaing - Chu63 - Clermont Ferrand

    RECRUITING

    Clermont-Ferrand, France

  • Hopital Haut-Leveque - Chu - Pessac

    RECRUITING

    Pessac, 33604, France

  • Hopital Le Bocage Chru Dijon

    RECRUITING

    Dijon, France

  • Hopital Purpan Chu

    RECRUITING

    Toulouse, France

  • Hopital Robert Debre Chu Reims

    RECRUITING

    Reims, France

  • Hopital St Eloi Chu Montpellier

    RECRUITING

    Montpellier, France

  • Hospices Civils de Lyon (Pierre Bénite,Edouard Herriot, La Croix Rousse)

    RECRUITING

    Lyon, France

  • Hu Est Parisien Site St Antoine Aphp

    RECRUITING

    Paris, France

  • Hu Paris Centre Site Cochin Aphp

    RECRUITING

    Paris, France

  • Hu Paris Nord Site Louis Mourier Aphp

    RECRUITING

    Colombes, France

  • Hu Paris Site Avicenne Aphp

    RECRUITING

    Bobigny, France

  • Hu Paris Sud Site Kremlin Bicetre Aphp

    RECRUITING

    Paris, France

  • Hu Saint Louis Site Saint Louis Aphp

    RECRUITING

    Paris, France

  • Hus/Hop Hautepierre

    RECRUITING

    Strasbourg, France

  • Icm - Montpellier

    RECRUITING

    Montpellier, France

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, France

  • Institut de Cancerologie de Lorraine

    RECRUITING

    Vandœuvre-lès-Nancy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.